JINLING PHARMACEUTICAL COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.15 CNY | -0.14% |
|
-1.79% | -9.15% |
ETFs positioned on Jinling Pharmaceutical Company Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.87% | - |
Jinling Pharmaceutical Company Limited is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicines and chemical drugs. The Companyâs main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The Company is also involved in the provision of medical services and the sale of medical instrument. The Company distributes its products in domestic market, with North China as its main market.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -9.15% | 624M | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 000919 Stock
- Funds and ETFs Jinling Pharmaceutical Company Limited
